We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCPC
376
Balchem Corp
BCPC
$5.51B
$4.55M 0.04%
47,963
-995
-2% -$93K
USPH icon
377
US Physical Therapy
USPH
$1.21B
$4.39M 0.03%
54,251
-900
-2% -$65.6K
QLYS icon
378
Qualys
QLYS
$5.44B
$4.33M 0.03%
41,600
-1,200
-3% -$126K
LVS icon
379
Las Vegas Sands
LVS
$30.4B
$4.24M 0.03%
93,150
-130,625
-58% -$6.14M
POWI icon
380
Power Integrations
POWI
$3.36B
$4.24M 0.03%
71,766
-1,400
-2% -$73.6K
ZD icon
381
Ziff Davis
ZD
$1.99B
$3.98M 0.03%
72,413
-1,102
-1% -$72K
TPIC
382
DELISTED
TPI Composites
TPIC
$3.97M 0.03%
169,712
-4,800
-3% -$90.1K
CVS icon
383
CVS Health
CVS
$135B
$3.95M 0.03%
60,800
+26,200
+76% +$1.65M
KTOS icon
384
Kratos Defense & Security Solutions
KTOS
$9.17B
$3.9M 0.03%
249,500
-8,000
-3% -$128K
FN icon
385
Fabrinet
FN
$16.3B
$3.88M 0.03%
62,173
-1,100
-2% -$67.5K
CPB icon
386
Campbell Soup
CPB
$6.66B
$3.82M 0.03%
+76,900
New +$3.82M
PLXS icon
387
Plexus
PLXS
$6.93B
$3.8M 0.03%
53,904
-900
-2% -$55.9K
PFGC icon
388
Performance Food Group
PFGC
$17.9B
$3.8M 0.03%
130,320
-3,018
-2% -$78.5K
QTS
389
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.75M 0.03%
58,468
-700
-1% -$44K
HMSY
390
DELISTED
HMS Holdings Corp.
HMSY
$3.73M 0.03%
115,002
-3,900
-3% -$113K
CBRE icon
391
CBRE Group
CBRE
$42.7B
$3.71M 0.03%
82,085
-5,100
-6% -$220K
ITGR icon
392
Integer Holdings
ITGR
$4.23B
$3.67M 0.03%
50,300
+3,500
+7% +$255K
AIT icon
393
Applied Industrial Technologies
AIT
$13B
$3.65M 0.03%
58,530
-570
-1% -$31.1K
AIN icon
394
Albany International
AIN
$2.16B
$3.52M 0.03%
59,967
-988
-2% -$53.4K
MCK icon
395
McKesson
MCK
$99.4B
$3.51M 0.03%
22,900
+8,000
+54% +$1.16M
MOH icon
396
Molina Healthcare
MOH
$10.2B
$3.41M 0.03%
19,172
-45,811
-70% -$7.8M
INTC icon
397
Intel
INTC
$456B
$3.37M 0.03%
56,300
+16,000
+40% +$957K
PPLI
398
People Inc
PPLI
$3.16B
$3.33M 0.03%
+57,633
New +$2.56M
QCOM icon
399
Qualcomm
QCOM
$159B
$3.32M 0.03%
36,400
-2,200
-6% -$176K
SUPN icon
400
Supernus Pharmaceuticals
SUPN
$2.63B
$3.25M 0.03%
136,735
-3,800
-3% -$84K

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.